Back to Search Start Over

Fatty liver and mortality: a cohort population study in South Italy

Authors :
Marisa Chiloiro
Anna Maria Cisternino
Antonio Logroscino
Valeria Tutino
Alberto Rubén Osella
Giovanni Misciagna
Vito Guerra
Rocco Guerra
Ornella Rotolo
Rosa Inguaggiato
Maria Notarnicola
Nicola Veronese
Rossella Donghia
Gioacchino Leandro
Giampiero De Leonardis
Caterina Bonfiglio
Rosa Reddavide
Maria Gabriella Caruso
Caruso, M.G.
Veronese, N.
Notarnicola, M.
Cisternino, A.M.
Reddavide, R.
Inguaggiato, R.
Guerra, V.
Donghia, R.
Logroscino, A.
Rotolo, O.
Chiloiro, M.
Leandro, G.
De Leonardis, G.
Tutino, V.
Misciagna, G.
Bonfiglio, C.
Guerra, R.
Osella, A.
Source :
BMJ Open
Publication Year :
2019
Publisher :
BMJ, 2019.

Abstract

ObjectiveAlcoholic fatty liver (AFLD) and non-alcoholic fatty liver (NAFLD) are two common conditions. However, if they can increase the risk of death is poorly explored. We therefore aimed to investigate the potential association between the presence and severity of liver steatosis and mortality in a large sample of older people.DesignProspective.SettingCommunity.ParticipantsWomen and men randomly sampled from the electoral rolls of the population of Castellana Grotte, a town in Southern Italy (Apulia region) between 2005 and 2006. Among 1942 initially contacted, 1708 (=87.9%) participated to the baseline survey (Multicentrica Colelitiasi III (MICOL III)). This specific study included 1445 older participants (mean age=65.2 years, females=44.2%).ExposureNAFLD or AFLD.Primary and secondary outcomesMortality (all-cause and specific-cause).ResultsAfter a median of 12 years, 312 participants (=21.6%) died. After adjusting for nine potential confounders, the presence of steatosis was not associated with any increased risk of death in both NAFLD and AFLD. The severity of liver steatosis was not associated with any increased risk of mortality in NAFLD, while in AFLD, the presence of moderate steatosis significantly increased the risk of overall (HR=2.16; 95% CI 1.19 to 3.91) and cancer-specific (HR=3.54; 95% CI 1.16 to 10.87) death.ConclusionsLiver steatosis is not associated with any increased risk of death in NAFLD, while moderate steatosis could be a risk factor for mortality (particularly due to cancer) in people affected by AFLD.

Details

ISSN :
20446055
Volume :
9
Database :
OpenAIRE
Journal :
BMJ Open
Accession number :
edsair.doi.dedup.....65ac55fe735214c8bd7c4d70f38851a8
Full Text :
https://doi.org/10.1136/bmjopen-2018-027379